Synthesis, SAR and molecular docking study of novel non-β-lactam inhibitors of TEM type β-lactamase

Bioorg Med Chem Lett. 2017 Apr 1;27(7):1588-1592. doi: 10.1016/j.bmcl.2017.02.025. Epub 2017 Feb 16.

Abstract

The novel classes of acylated phenoxyanilide and thiourea compounds were investigated for their ability to inhibit TEM type β-lactamase enzyme. Two compounds 4g and 5c reveal the inhibition potency in micromolar range and show their action by non-covalent binding in the vicinity of the TEM-171 active site. The structure activity relationship around carbon chain length and different substituents in ortho- and para-positions of acylated phenoxyanilide as well as molecular modelling study has been performed.

Keywords: Acylated phenoxyaniline; Molecular docking; TEM type β-lactamase; Thiourea; β-Lactamase inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anilides / chemistry
  • Catalytic Domain
  • Escherichia coli Proteins / antagonists & inhibitors*
  • Escherichia coli Proteins / chemistry
  • Hydrogen Bonding
  • Kinetics
  • Molecular Docking Simulation
  • Phenyl Ethers / chemistry
  • Structure-Activity Relationship
  • Thiourea / analogs & derivatives*
  • Thiourea / chemistry
  • beta-Lactamase Inhibitors / chemistry*
  • beta-Lactamases / chemistry*

Substances

  • 4-((4-(2,4-dichloro)phenoxyphenyl)-4-carboxyphenyl)thiourea
  • Anilides
  • Escherichia coli Proteins
  • Phenyl Ethers
  • beta-Lactamase Inhibitors
  • beta-Lactamases
  • beta-lactamase TEM-171, E coli
  • Thiourea